TelyRx Holdings Inc. shares surged nearly 8% in today's trading, fueled by exciting news and opportunities for investor engagement.
TelyRx Holdings Inc. (TELY.TO) saw its stock price jump by 7.92% in the last trading session, closing at CA$2.59. This impressive gain follows the company's upcoming presentation at the Small Cap Growth Virtual Investor Conference, which has sparked investor interest.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$66.45M
52W high
$4.25
52W low
$2.00
1W change
+2.94%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 144.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+144.9% Upside
Current Price
C$2.45
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
83.1%
Annualized
90-Day Vol
92.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.05
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.31 | C$1.73 โ C$3.07 |
| 60 trading days | C$2.18 | C$1.45 โ C$3.26 |
| 90 trading days | C$2.05 | C$1.25 โ C$3.37 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors are responding positively to TelyRx's strategic engagement with the market, showing strong belief in the company's growth potential.
TelyRx Holdings Inc. Stock Rises by 7.92%
With a market cap of CA$58.47 million, TelyRx's stock performance reflects growing investor confidence in its business model and future prospects.
Bull case
The upcoming conference is a great chance for TelyRx to showcase its innovative healthcare solutions. This could attract new investors and drive the stock price even higher.
Bear case
Despite the positive momentum, TelyRx's lack of profitability and high market expectations could pose risks if the company doesn't meet investor hopes.
Investor Conference Sparks Interest
TelyRx's participation in the Small Cap Growth Virtual Investor Conference on June 4, 2026, is a key factor in its stock performance. The event allows investors to engage directly with company executives, promoting transparency and potential future growth. Such opportunities often boost investor confidence, as we saw in today's trading.
Market Reaction and Future Outlook
The 7.92% increase in TelyRx's stock price shows a positive market reaction to the company's strategic initiatives. However, investors should stay cautious. The company's current profit margin is negative, and while the conference may improve visibility, TelyRx needs to deliver tangible results to keep investor enthusiasm. For more insights on TelyRx, visit our detailed analysis here.
Advertisement
